Latest Breaking News On - Liposomal bcl - Page 1 : comparemela.com

Arq, Inc (NASDAQ:ARQ) Q1 2024 Earnings Call Transcript

Arq, Inc (NASDAQ:ARQ) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Stacia hansenLiposomal bclRobert rasmusBob rasmusAnthony nathanSecurities exchangeLarq incExchange commissionCall transcript mayArq first quarterChief executive officerChief accountingInvestor relationsAsset sizeGreek statesRed river

Arcadium Lithium plc (NYSE:ALTM) Q1 2024 Earnings Call Transcript

Arcadium Lithium plc (NYSE:ALTM) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

James bayCanada generalUnited statesRobert steinDaniel rosenKevin mccarthyDavid deckelbaumJohn robertsGilberto antoniazziLiposomal bclExchange commissionResearch partnersArcadium lithium plcArcadium lithiumCall transcript mayFirst quarter

BASF SE (PNK:BASFY) Q4 2023 Earnings Call Transcript

BASF SE (PNK:BASFY) Q4 2023 Earnings Call Transcript February 23, 2024 BASF SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Stefanie Wettberg: Good morning, ladies and gentlemen. Welcome to BASF’s Conference Call on the Fourth Quarter and Full Year 2023 […]

United statesLiposomal bclAgricultural solutionsIndustrial solutionsHenry hubNorth americaSurface technologiesBuy the dip stocks to rightLadies and gentlemenMartin brudermullerConference callChemical productionForward looking statements

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

HOUSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) Bio-Path Holdings, Inc. (NASDAQ: BPTH) (the “Company”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of

United statesLiposomal bclDoug morrisEquiniti trust companyPath holdingsPath holdings incStern investor relations incExchange commissionEastern timeNasdaq capital marketBio path holdingsAnnual reportInvestor relations

Comparing Bio-Path (NASDAQ:BPTH) & MannKind (NASDAQ:MNKD)

Bio-Path (NASDAQ:BPTH – Get Free Report) and MannKind (NASDAQ:MNKD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Institutional & Insider Ownership 5.7% of Bio-Path shares are […]

United statesLiposomal bclVertice pharmaUnited therapeutics corporationCipla ltdPath holdings incMannkind corporationGet free reportGiven mannkindPath holdingsKind corporationBio path dailyBio pathNasdaq bpthStock comparisonStock analysis